Interleukin‐33 (IL‐33), fetuin A, and CK‐18 have emerged as significant mediators of inflammatory and apoptotic pathways in CAD [5, 6, 7, 8, 9, 10, 11, 12, 13]. The gene discussed is IL33; the disease is coronary artery disorder.